Home/Filings/3/0001179110-04-019200
3//SEC Filing

ESSEX WOODLANDS HEALTH VENTURES FUND V LP 3

Accession 0001179110-04-019200

CIK 0000786947other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 12:15 PM ET

Size

9.0 KB

Accession

0001179110-04-019200

Insider Transaction Report

Form 3
Period: 2004-08-13
Holdings
  • Common Stock

    114,477
  • Series A Preferred Stock

    From: 2004-08-13Common Stock (33,909,751 underlying)
  • Series B Preferred Stock

    From: 2004-08-13Common Stock (6,756,207 underlying)
  • Series C-3 Preferred Stock

    From: 2004-08-13Common Stock (15,593,247 underlying)
  • Common Stock Purchase Warrant

    Exercise: $0.34From: 2003-05-08Exp: 2010-05-08Common Stock (345,000 underlying)
Footnotes (3)
  • [F1]Shares of the issuer's Preferred Stock are convertible into shares of the issuer's Common Stock for as long as such shares are outstanding.
  • [F2]Shares of the issuer's Series A Preferred Stock currently are convertible into shares of the issuer's Common Stock on a 5-for-1 basis.
  • [F3]Shares of the issuer's Series B Preferred Stock and Series C-3 Preferred Stock currently are convertible into shares of the issuer's Common Stock on a 1-for-1 basis.

Issuer

ACURA PHARMACEUTICALS, INC

CIK 0000786947

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001120812

Filing Metadata

Form type
3
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 12:15 PM ET
Size
9.0 KB